Mattila Anne, Luhtala Jussi, Mrena Johanna, Kautiainen Hannu, Kellokumpu Ilmo
Department of Surgery, Central Hospital of Central Finland, Keskussairaalantie 19, 40620, Jyväskylä, Finland.
Surg Endosc. 2014 Dec;28(12):3451-7. doi: 10.1007/s00464-014-3620-9. Epub 2014 Jun 18.
To audit short- and long-term outcomes after laparoscopic common bile duct exploration (LCBDE) and factors influencing the success of the laparoscopic treatment.
From January 1999 to December 2011, 288 patients (93 males) underwent a single-stage laparoscopic cholecystectomy combined with LCBDE in two Finnish Hospitals. Short-term outcome data were collected prospectively. Long-term outcomes were examined retrospectively. The main measures of outcome were the success of laparoscopic CBD stone clearance and recurrence of CBD stones in the long-term, with 30-day mortality, morbidity, and the length of postoperative hospital stay as secondary outcome measures.
CBD stones were successfully removed by one-stage laparoscopic procedure in 232 of the 279 patients (83.2%) with verified CBD stones and after conversion to open surgery in additional 28 patients (93.2%). Nineteen patients (6.8%) having residual stones after surgery were successfully treated with postoperative ERCP. On multivariate analysis, the independent factors associated with a failed laparoscopic stone clearance were stone size over 7 mm [OR 3.51 (95% CI 1.53-8.03), p = 0.003], difficult anatomy [OR 18.01 (5.03-64.49), p < 0.001] and transcholedochal approach [OR 2.98 (1.37-4.47), p = 0.006]. Laparoscopic stone clearance also failed in all 11 patients having impacted stones at the ampulla of Vater. Cumulative long-term recurrence rate was 3.6% at 5 years and 6.0 % at 10 years. Thirty-day mortality was 0.3% and morbidity 12.2%. Postoperative hospital stay was median 2 (IQR 1-3) days after transcystic CBD removal and 4 (IQR 3-7) days after transcholedochal CBD removal, p < 0.001.
Our results show that one-stage LC combined with LCBDE stone clearance is safe and effective in most patients thus reducing the number of additional, potentially dangerous endoscopic procedures. Moreover, large or impacted stones are a risk factor for failed stone clearance.
评估腹腔镜胆总管探查术(LCBDE)的短期和长期疗效以及影响腹腔镜治疗成功的因素。
1999年1月至2011年12月,芬兰两家医院的288例患者(93例男性)接受了一期腹腔镜胆囊切除术联合LCBDE。前瞻性收集短期疗效数据,回顾性检查长期疗效。主要疗效指标为腹腔镜清除胆总管结石的成功率和胆总管结石的长期复发率,次要疗效指标为30天死亡率、发病率和术后住院时间。
279例经证实有胆总管结石的患者中,232例(83.2%)通过一期腹腔镜手术成功清除结石,另外28例(93.2%)转为开放手术后成功清除结石。19例(6.8%)术后有残留结石的患者通过术后内镜逆行胰胆管造影(ERCP)成功治疗。多因素分析显示,与腹腔镜结石清除失败相关的独立因素为结石大小超过7mm[比值比(OR)3.51(95%置信区间1.53 - 8.03),p = 0.003]、解剖结构复杂[OR 18.01(5.03 - 64.49),p < 0.001]和经胆总管途径[OR 2.98(1.37 - 4.47),p = 0.006]。所有11例在Vater壶腹有嵌顿结石的患者腹腔镜结石清除也失败。5年累计长期复发率为3.6%,10年为6.0%。30天死亡率为0.3%,发病率为12.2%。经胆囊管胆总管切除术后住院时间中位数为2(四分位间距1 - 3)天,经胆总管胆总管切除术后为4(四分位间距3 - 7)天,p < 0.001。
我们的结果表明,一期腹腔镜胆囊切除术联合LCBDE结石清除术对大多数患者是安全有效的,从而减少了额外的、潜在危险的内镜手术数量。此外,大结石或嵌顿结石是结石清除失败的危险因素。